Terminated NA INTERVENTIONAL 2-arm NCT01850771

Regenexx™ PL-Disc Versus Steroid Epidurals for Lumbar Radiculopathy

A Single-Blinded, Randomized Controlled Trial of Regenexx™ PL-Disc Versus Steroid Epidurals for Treatment of Lumbar Radiculopathy

Sponsor: Regenexx, LLC

Conditions Disc Degeneration Herniated Disc Radiculopathy

Interventions Regenexx PL-Disc Steroid Epidural

Updated 6 times since 2017 Last updated: Jun 1, 2016 Started: May 31, 2013 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficulties in recruitment

Other terminated trials from Regenexx, LLC

More terminations from Regenexx, LLC

Listed as NCT01850771, this NA trial focuses on Disc Degeneration and Herniated Disc and remains terminated or withdrawn. Sponsored by Regenexx, LLC, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Aug 2018 — Jan 2021 [monthly]

Terminated NA
Jun 2018 — Aug 2018 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regenexx, LLC

Data source: Regenexx, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Broomfield, United States